By

AbbVie announced that the European Commission has granted marketing authorizations for its all-oral, short-course, interferon-free treatment of VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) +...

By

NovoBiotic Pharmaceuticals, LLC announces the discovery and preclinical development of teixobactin, a compound belonging to a new class of antibiotics. As reported in the journal Nature (Ling et. al....

By

New Jersey pharmaceutical company, Valeant Pharmaceuticals has announced the recall of one lot of the powdered antiviral drug,  Virazole® (ribavirin powder for solution) due to microbial contamination. Virazole...

By

On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious respiratory illness caused...

By

The U.S. Food and Drug Administration today approved Zerbaxa (ceftolozane/tazobactam), a new antibacterial drug product, to treat adults with complicated intra-abdominal infections (cIAI) and complicated...

By

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV)...

By

The U.S. Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used to treat acute otitis externa, commonly known as swimmer’s ear. Acute otitis externa is an...

By

PRESS RELEASE Basilea Pharmaceutica Ltd. announced  Friday that its broad-spectrum antibiotic, Zevtera® (ceftobiprole medocaril) has been launched in Germany. The European Centre for Disease Prevention...

By

Biopharmaceutical company, Cellceutix Corporation announced today that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) designation for Brilacidin as...

By

PRESS RELEASE Researchers at the University of Liverpool have demonstrated a new treatment against antibiotic resistant bacterial infections. Published in Nature Biotechnology, the study showed that...